{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:36:33Z","timestamp":1793331393829,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2314-B-002-269111-2320-B-002-016-MY3"],"award-info":[{"award-number":["110-2314-B-002-269111-2320-B-002-016-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2320-B-002-016-MY3"],"award-info":[{"award-number":["111-2320-B-002-016-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2314-B-002-269"],"award-info":[{"award-number":["110-2314-B-002-269"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2811-B-002-093"],"award-info":[{"award-number":["111-2811-B-002-093"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["108-2811-B-002-542"],"award-info":[{"award-number":["108-2811-B-002-542"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["108-2320-B-002-032-MY3"],"award-info":[{"award-number":["108-2320-B-002-032-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biopha.2025.117958","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T23:46:18Z","timestamp":1741477578000},"page":"117958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Atypical antipsychotics impair the lipid-lowering and pleiotropic effects of simvastatin via activation of the ADMA-NOX-ROS pathway"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-4993","authenticated-orcid":false,"given":"Chia-Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Po","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9593-4062","authenticated-orcid":false,"given":"Tzong-Shyuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117958_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-017-0293-z","article-title":"Targeting metabotropic glutamate receptors for novel treatments of schizophrenia","volume":"10","author":"Maksymetz","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.biopha.2025.117958_bib2","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.117958_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117958_bib4","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.117958_bib5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1159\/000494573","article-title":"Atypical antipsychotic drug olanzapine deregulates hepatic lipid metabolism and aortic inflammation and aggravates atherosclerosis","volume":"50","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2025.117958_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154847","article-title":"Atypical antipsychotic drugs deregulate the cholesterol metabolism of macrophage-foam cells by activating NOX-ROS-PPAR\u03b3-CD36 signaling pathway","volume":"123","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2025.117958_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","article-title":"Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies","volume":"40","author":"Hirsch","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.biopha.2025.117958_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.psychres.2017.11.033","article-title":"Statin add-on therapy in the antipsychotic treatment of schizophrenia: a meta-analysis","volume":"260","author":"Nomura","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopha.2025.117958_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12888-016-1006-3","article-title":"Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study","volume":"16","author":"Solberg","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopha.2025.117958_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3949\/ccjm.88a.20165","article-title":"Statin intolerance and new lipid-lowering treatments","volume":"88","author":"Mesi","year":"2021","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.biopha.2025.117958_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.38212\/2224-6614.3472","article-title":"Autophagy\u2013urea cycle pathway is essential for the statin-mediated nitric oxide bioavailability in endothelial cells","volume":"31","author":"Chen","year":"2023","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biopha.2025.117958_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116192","article-title":"Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: interlocking biology between eNOS activity and L-arginine metabolism","volume":"171","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.117958_bib13","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0019","article-title":"Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia","volume":"11","author":"Chan","year":"2022","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.biopha.2025.117958_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/antiox12020477","article-title":"Di-(2-ethylhexyl) phthalate limits the lipid-lowering effects of simvastatin by promoting protein degradation of low-density lipoprotein receptor: role of PPAR\u03b3-PCSK9 and LXR\u03b1-IDOL signaling pathways","volume":"12","author":"Guo","year":"2023","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2025.117958_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","article-title":"The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature","volume":"13","author":"Diamantis","year":"2017","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.biopha.2025.117958_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0735-1097(03)00082-2","article-title":"Antioxidants, statins, and atherosclerosis","volume":"41","author":"Gotto","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.117958_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003327","article-title":"Asymmetric dimethylarginine limits the efficacy of simvastatin activating endothelial nitric oxide synthase","volume":"5","author":"Hsu","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.117958_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000973","article-title":"Aging of the nitric oxide system: are we as old as our NO?","volume":"3","author":"Sverdlov","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.117958_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001833","article-title":"Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies","volume":"4","author":"Willeit","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.117958_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.187310","article-title":"Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables","volume":"59","author":"Wilcox","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2025.117958_bib21","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117958_bib22","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117958_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.107.156901","article-title":"Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2","volume":"101","author":"Hasegawa","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117958_bib24","doi-asserted-by":"crossref","first-page":"H1058","DOI":"10.1152\/ajpheart.01103.2007","article-title":"Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice","volume":"194","author":"Jacobi","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117958_bib25","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2353\/ajpath.2010.090614","article-title":"Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine","volume":"176","author":"Jacobi","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.117958_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ndt\/gft439","article-title":"Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2025.117958_bib27","doi-asserted-by":"crossref","first-page":"23667","DOI":"10.1074\/jbc.M112.350181","article-title":"Peroxisome proliferator-activated receptor \u03b3 activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression","volume":"287","author":"Duan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117958_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.117958_bib29","first-page":"103","article-title":"J, Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression","volume":"27","author":"Wu","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2025.117958_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1194\/jlr.M067488","article-title":"Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice","volume":"57","author":"Schonewille","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2025.117958_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2019.09.022","article-title":"Cholesterol in LDL receptor recycling and degradation","volume":"500","author":"Yang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2025.117958_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117958_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","article-title":"Statins and inflammation: new therapeutic opportunities in psychiatry","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117958_bib34","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jcp.27254","article-title":"PCSK9: a novel inflammation modulator in atherosclerosis?","volume":"234","author":"Tang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2025.117958_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/mmr.2021.11970","article-title":"Cigarette smoke extract stimulates PCSK9 production in HepG2 cells via ROS\/NF\u2011\u03baB signaling","volume":"23","author":"Ma","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.117958_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bpj.2016.05.034","article-title":"Shear-induced nitric oxide production by endothelial cells","volume":"111","author":"Sriram","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2025.117958_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.freeradbiomed.2019.08.016","article-title":"The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells: role of the NOX\/ROS signaling","volume":"143","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.117958_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/antiox12010072","article-title":"Bromelain ameliorates atherosclerosis by activating the tfeb-mediated autophagy and antioxidant pathways","volume":"12","author":"Chen","year":"2022","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2025.117958_bib39","first-page":"663","article-title":"Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death","volume":"18","author":"D'Errico","year":"2021","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.biopha.2025.117958_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00498254.2015.1078522","article-title":"Involvement of oxidative stress and mitochondrial\/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes","volume":"46","author":"Eftekhari","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2025.117958_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102108","article-title":"Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine\/dimethylarginine dimethylaminotransferase 2 pathway","volume":"46","author":"Lee","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.117958_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41401-019-0212-1","article-title":"Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:17:09Z","timestamp":1744258629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"alternative-id":["S0753332225001520"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117958","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical antipsychotics impair the lipid-lowering and pleiotropic effects of simvastatin via activation of the ADMA-NOX-ROS pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117958"}}